15th INTERNATIONAL CONGRESS OF PARKINSON'S

Abstracts
by topic
114
Abstracts by Topic
803 Synchronized beta oscillations across pallidal nuclei strengthen in
the moderately parkinsonian non-human primate
A.L. Jensen, K.B. Baker, J.L. Vitek (Minneapolis, Minnesota, USA)
804 Electrophysiological evaluation using transcranial magnetic
stimulation for progressive supranuclear palsy, idiopathic normal
pressure hydrocephalus, and Parkinson’s disease
T. Kawakami, K. Fujimoto, I. Nakano (Shimotsuke, Tochigi, Japan)
805 Increased cortical plasticity in early untreated Parkinson’s disease
M. Kojovic, M. Bologna, P. Kassavetis, N. Murase, P. Schwingenschuh,
A. Berardelli, J.C. Rothwell, M.J. Edwards, K.P. Bhatia (London, United
Kingdom)
806 Peripheral nerve and musculoskeletal complications in patients with
Parkinson’s disease
R. Lugo, N. Galvez-Jimenez (Weston, Florida, USA)
807 Bidirectional coupling between motor cortex and muscle activity in
rest tremor in Parkinson’s disease
J. Modolo, A. Beuter, J. Cates, M. Jog, A. Burhan, F.S. Prato,
A.W. Thomas, A.G. Legros (London, Ontario, Canada)
808 Attention modulation regulates both motor and non-motor
performance in Parkinson’s disease: A high-density EEG study
C. Moisello, B. Perfetti, S. Lanzafame, S. Varanese, E. Landsness,
M. Onofrj, A. Di Rocco, G. Tononi, M.F. Ghilardi (New York, New
York, USA)
809 EMG findings in Parkinson’s disease patients with peripheral nerve
injuries
J.A. Morren, R. Lugo, N. Galvez-Jimenez (Weston, Florida, USA)
810 Effects of standard L-Dopa on saccadic eye movements in patients
with mild-stage Parkinson’s disease
J.-H. Park, J.-Y. Park, S.-A. Park, T.-K. Lee, K.-B. Sung (Bucheon-si,
Kyeonggi-do, Korea)
811 Amiodarone and its effect on microelectrode recording (MER)
during deep brain stimulation surgery
M. Parvaresh Rizi, G. Shahidi (Tehran, Islamic Republic of Iran)
812 Comparison of anatomical methods and physiologic method for
targeting subthalamic nucleus (STN) in deep brain stimulation in
Parkinson’s disease
M. Parvaresh Rizi, G. Shahidi, M. Hamidifard, A. Tabibkhoei (Teahran,
Islamic Republic of Iran)
813 Levopoda intake does not influence neuromuscular activation and
coactivation levels around the knee on Parkinson’s disease patients
M.P. Pereira, N.M. Rinaldi, L.T.B. Gobbi, F. Stella (Rio Claro, São
Paulo, Brazil)
814 Combined measures of movement and force variability distinguish
patients with Parkinson’s disease (PD) from essential tremor (ET)
C. Poon, J.A. Robichaud, D.M. Corcos, J.G. Goldman,
D.E. Vaillancourt (Chicago, Illinois, USA)
815 Stationary of hyperacute and long-term subthalamic local field
potential oscillations during ongoing subthalamic deep brain
stimulation in Parkinson’s disease
M. Rosa, G. Giannicola, D. Servello, S. Marceglia, C. Pacchetti,
M. Porta, M. Sassi, E. Scelzo, S. Barbieri, A. Priori (Milan, Italy)
816 High frequency oscillations in the subthalamic nucleus: A
neurophysiological marker of the motor state in Parkinson’s disease
T.E. Özkurt, M. Butz, M. Homburger, S. Elben, J. Vesper, L. Wojtecki,
A. Schnitzler (Duesseldorf, Germany)
817 Basal ganglia oscillations during gait in parkinsonian patients
A. Singh, S. Kammermeier, A. Plate, J. Ilmberger, K. Bötzel (Munich,
Germany)
818 Relationship between subthalamic nucleus oscillatory activity and
age, gender, and clinical features in Parkinson’s disease
J. Toledo, M. Alegre, J. López-Azcarate, J. Guridi, J. Iriarte, J. Obeso,
J. Artieda, M.C. Rodriguez-Oroz (Pamplona, Spain)
819 Different effect of alpha, low beta and high beta activities in
subthalamic nucleus by volitional movement initiation in patients
with Parkinson’s disease
C.-H. Tsai, H.-Y. Lai, Y.-T. Hsu, T.-F. Chien, S.-M. Chiou, S.-Z. Lin,
M.-K. Lu, Y.C. Lin, Y.-Y. Chen (Taichung, Taiwan)
820 Assessment of brainstem function with vagus nerve sensory evoked
potentials in Parkinson’s disease
D. Weise, A. Melanie, R. Jost-Julian, C. Joseph (Leipzig, Germany)
821 Co-activation of antagonistic muscles in Parkinson’s disease as a
pathophysiological mechanism of PD motor impairment
D. Weiss, R. Klotz, A. Ramos, G. Naros, F. Grimm, F. Bunjes, T. Gasser,
T. Wächter, S. Breit, R. Krüger, A. Gharabaghi (Tübingen, Germany)
822 Attenuation of beta band hypersynchrony during deep brain
stimulation is greater within than above the subthalamic nucleus in
Parkinson’s disease
D. Whitmer, C. de Solages, B.C. Hill, H.M. Yu, J.M. Henderson,
H. Bronte-Stewart (Stanford, California, USA)
823 Efficacy of dopaminergic medication on neural and non-neural
components of rigidity in Parkinson’s disease
R. Xia, N. Hanson, D. Powell, A. Muthumani, J. Bertoni, A.J. Threlkeld
(Omaha, Nebraska, USA)
824 Saccade-related beta desynchronization in the human subthalamic
nucleus
A. Yugeta, A. Sundaram, A.M. Lozano, M. Hodaie, W.D. Hutchison,
R. Chen (Toronto, Ontario, Canada)
Parkinson’s disease: Neuropharmacology
825 Effects of amantadine withdrawal after long-term use in Parkinson’s
disease
F. Akhtar, M.L. Rajput, A. Rajput, A.H. Rajput (Saskatoon,
Saskatchewan, Canada)
826 Electrogastrographyc activity in patients with Parkinson’s disease
with and without motor fluctuations
G. Albani, N. El Assawy, S. Cattaldo, M. De Gennaro, L. Pradotto,
A. Mauro (Piancavallo, Verbania, Italy)
827 Neuroprotective effect of pegylated G-CSF in parkinsonian nonhuman
primates
R. Aron Badin, T. Frank, P. Hantraye, M. Bähr, N. Deglon, J. Weishaupt
(Fontenay-aux-Roses, France)
828 Prevalence of neuropathy in patients with Parkinson’s disease and
relationship with L-dopa exposure: Preliminary data a longitudinal
multicentric study
U. Bonuccelli, G. Cossu, P. Borelli, R. Ceravolo, C. Logi, M. Bandettini,
C. Rossi, D. Frosini, A. Paribello, D. Manca, R. Marchese,
G. Abbruzzese (Pisa, Italy)